The company also reported full year net sales of $8.3 billion in 2011, which is a 13.5 percent increase from 2010. United States sales increased by 9.4 percent to $1.4 billion and international sales showed a 14 percent increase to $808 million during the fourth quarter. The company spent $28 million in acquisition-related charges during the fourth quarter, after acquiring companies such as Orthovita and Concentric.
The company’s knee sales experienced a 2 percent decrease in sales to $341 million during the fourth quarter. Stryker’s spine business reported a 6 percent 4Q increase to $178 million and the neurotechnology business had a 126 percent increase to $199 million. Stryker hip sales remained flat, at $314 million.
Related Articles on Orthopedic Devices:
Life Spine Reports 29% Revenue Growth in 2011
Costs Mount for DePuy ASR Hip Recall Program as DePuy Sees US Sales Drop
Medtronic Receives FDA Clearance for Surgical Device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.